Satellite Bio

Satellite Bio is a private, pre-clinical stage biotech focused on creating a scalable, off-the-shelf liver cell therapy. Its core technology leverages the regenerative capacity of hepatocytes, aiming to treat liver failure by directly restoring functional cell mass. The company's approach emphasizes drug-like manufacturing and practical logistics to overcome traditional cell therapy challenges. Led by an interdisciplinary team of experts, Satellite Bio is positioning itself to tackle a significant unmet medical need in hepatology.

Proprietary platform for developing off-the-shelf, expandable hepatocyte (liver cell) therapies designed for scalable, drug-like manufacturing and global distribution.

Competition includes other cell therapy approaches (e.g., stem cell-derived hepatocytes), gene therapies for specific liver disorders, bioartificial liver support devices, and companies developing liver tissue engineering solutions. Satellite Bio differentiates itself with a strong focus on off-the-shelf practicality and scalable manufacturing.